Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Vered Caplan, BSc, Orgenesis, Germantown, MD, discusses a collaboration between Orgenesis and University of California, Davis (UC Davis), which will focus on the production and development of cellular therapies, and a collaboration between Orgenesis and a Korean company. This interview took place during the ESMO TAT 2021 conference.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.